| 12001 | PPP1R14D levels | GCST90470303 | 5.21e-06 |
| 12002 | Omega-3 fatty acids to total fatty acids percentage | GCST90502460 | 5.18e-06 |
| 12003 | ATOX1/TMSB10 ratio | GCST90313377 | 5.18e-06 |
| 12004 | Spirits liking | GCST90094848 | 5.18e-06 |
| 12005 | TNFSF12 levels | GCST90274846 | 5.17e-06 |
| 12006 | IDP dMRI ProbtrackX L1 slf r | GCST90004268 | 5.12e-06 |
| 12007 | Prescriptions - ACE inhibitor|anti-hypertensive | UKBB00000657 | 5.09e-06 |
| 12008 | OSM levels | GCST90470133 | 5.09e-06 |
| 12009 | Type 1 diabetes | GCST90014023 | 5.04e-06 |
| 12010 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T47 | ECGU000047 | 4.94e-06 |
| 12011 | Crohns disease | GCST90468121 | 4.94e-06 |
| 12012 | CEACAM21 levels | GCST90468694 | 4.80e-06 |
| 12013 | Neutrophill percentage | Blood count | UKBB00000498 | 4.79e-06 |
| 12014 | LRCH4 levels | GCST90469791 | 4.69e-06 |
| 12015 | Breast cancer | GCST90018579 | 4.50e-06 |
| 12016 | VWC2L levels | GCST90471063 | 4.48e-06 |
| 12017 | Physical activity (Total log acceleration) | GCST90061408 | 4.47e-06 |
| 12018 | ADD1 levels | GCST90468233 | 4.44e-06 |
| 12019 | Types of physical activity in last 4 weeks - Heavy DIY (eg: weeding, lawn mowing, carpentry, digging) | Physical activity | UKBB00000870 | 4.42e-06 |
| 12020 | Sphingomyelin_33:1_[M+H]1+ levels | GCST90060229 | 4.39e-06 |
| 12021 | Chronic heart failure | GCST90018586 | 4.38e-06 |
| 12022 | CD4/LILRB4 ratio | GCST90313843 | 4.31e-06 |
| 12023 | Actinic keratosis | FING00000013 | 4.25e-06 |
| 12024 | ADAMTS15 levels | GCST90468223 | 4.24e-06 |
| 12025 | Iron deficiency anaemia | FING00000699 | 4.22e-06 |
| 12026 | Coffee intake (standard GWA) | GCST90267274 | 4.19e-06 |
| 12027 | FAM3B/FUT3_FUT5 ratio | GCST90314777 | 4.17e-06 |
| 12028 | aparc-Desikan lh area precuneus | GCST90003097 | 4.14e-06 |
| 12029 | T1 FreeSurfer aseg Right-choroid-plexus | GCST90384170 | 4.12e-06 |
| 12030 | Lymphocyte count | Blood count | UKBB00000411 | 4.09e-06 |
| 12031 | Accelerometer-based physical activity measurement (average acceleration) | GCST006099 | 4.08e-06 |
| 12032 | KDM3A levels | GCST90469671 | 4.02e-06 |
| 12033 | HPCAL1/MPIG6B ratio | GCST90315073 | 4.01e-06 |
| 12034 | aparc-a2009s lh thickness G-cuneus | GCST90003613 | 3.97e-06 |
| 12035 | TNFRSF11A levels | GCST90277644 | 3.88e-06 |
| 12036 | Plasma sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)* levels in chronic kidney disease | GCST90265971 | 3.84e-06 |
| 12037 | Clonal hematopoiesis (DNMT3A mutation) | GCST90435354 | 3.81e-06 |
| 12038 | PPM1F levels | GCST90470297 | 3.79e-06 |
| 12039 | Paroxysmal tachycardia | FING00001151 | 3.73e-06 |
| 12040 | Herring liking | GCST90094781 | 3.70e-06 |
| 12041 | MAVS/RNF41 ratio | GCST90315395 | 3.67e-06 |
| 12042 | ABHD14B/SPARC ratio | GCST90313146 | 3.64e-06 |
| 12043 | Nonsuppurative otitis media | FING00000885 | 3.61e-06 |
| 12044 | Neutrophill percentage (UKB data field 30200) | GCST90468093 | 3.61e-06 |
| 12045 | Stroke (MTAG) | GCST90449063 | 3.56e-06 |
| 12046 | CD79B/ICAM3 ratio | GCST90313901 | 3.48e-06 |
| 12047 | Alcoholic liver disease | FING00000057 | 3.47e-06 |
| 12048 | SCGB3A2 levels | GCST90470543 | 3.47e-06 |
| 12049 | Interpolated Year when non-cancer illness first diagnosed | Medical conditions | UKBB00000371 | 3.44e-06 |
| 12050 | TRIM5 levels | GCST90470970 | 3.43e-06 |
| 12051 | Hashimoto thyroiditis | GCST90018635 | 3.43e-06 |
| 12052 | Breast cancer | GCST007236 | 3.39e-06 |
| 12053 | CD27/TNFRSF13B ratio | GCST90313777 | 3.38e-06 |
| 12054 | MS-disease / Multiple Sclerosis | FING00000839 | 3.36e-06 |
| 12055 | Ulcerative colitis | GCST90446795 | 3.35e-06 |
| 12056 | Physical activity | GCST90093322 | 3.33e-06 |
| 12057 | DTI TBSS MD Posterior limb of internal capsule L | GCST90384591 | 3.32e-06 |
| 12058 | Mean arterial pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000443 | 3.32e-06 |
| 12059 | aparc-a2009s lh area G-oc-temp-med-Lingual | GCST90003318 | 3.31e-06 |
| 12060 | DDC levels | GCST90468967 | 3.29e-06 |
| 12061 | Hypertensive Heart Disease | FING00000639 | 3.29e-06 |
| 12062 | Type 1 diabetes with ketoacidosis (PheCode 250.11) | GCST90475662 | 3.26e-06 |
| 12063 | Seborrheic keratosis (PheCode 702.2) | GCST90476206 | 3.23e-06 |
| 12064 | Body fat rate | GCST90278619 | 3.21e-06 |
| 12065 | QC T2 FLAIR-to-T1 linear alignment discrepancy | GCST90006350 | 3.20e-06 |
| 12066 | GSTA1/KRT18 ratio | GCST90314993 | 3.20e-06 |
| 12067 | Varicose veins | GCST90086144 | 3.14e-06 |
| 12068 | Active to sedentary transition probability | GCST90061429 | 3.12e-06 |
| 12069 | FABP1/FABP2 ratio | GCST90314750 | 3.09e-06 |
| 12070 | CD27/FCRL5 ratio | GCST90313772 | 3.06e-06 |
| 12071 | FIS1/PDGFB ratio | GCST90314830 | 3.03e-06 |
| 12072 | lymphocyte (fraction, mean, inv-norm transformed) | GCST90475435 | 3.00e-06 |
| 12073 | XPNPEP2 levels | GCST90471084 | 2.94e-06 |
| 12074 | aseg global volume WM-hypointensities | GCST90002604 | 2.94e-06 |
| 12075 | KLRD1/LY9 ratio | GCST90315261 | 2.88e-06 |
| 12076 | Blood cell traits latent factor 22 (white cell) | GCST90559264 | 2.88e-06 |
| 12077 | DNA methylation PhenoAge acceleration | GCST90014292 | 2.80e-06 |
| 12078 | Blood cell traits latent factor 9 (white cell) | GCST90559251 | 2.76e-06 |
| 12079 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T304 | ECGA000304 | 2.75e-06 |
| 12080 | Degeneration of macula and posterior pole of retina (PheCode 362.2) | GCST90475849 | 2.74e-06 |
| 12081 | lymphocyte (fraction, maximum, inv-norm transformed) | GCST90475432 | 2.72e-06 |
| 12082 | MGAT2 levels | GCST90089560 | 2.70e-06 |
| 12083 | Type1 diabetes, definitions combined, early onset | FING00001384 | 2.67e-06 |
| 12084 | White bread liking | GCST90094865 | 2.67e-06 |
| 12085 | PDE5A levels | GCST90470187 | 2.62e-06 |
| 12086 | Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35) | GCST90309369 | 2.61e-06 |
| 12087 | Thyroid peroxidase antibody positivity with euthyroid in pregnancy | GCST90435203 | 2.59e-06 |
| 12088 | LRP11/ROR1 ratio | GCST90315330 | 2.57e-06 |
| 12089 | F2R/TNFRSF14 ratio | GCST90314739 | 2.55e-06 |
| 12090 | CCL19 levels | GCST90468571 | 2.45e-06 |
| 12091 | F-wine liking (derived food-liking factor) | GCST90094872 | 2.35e-06 |
| 12092 | IL19 levels | GCST90469568 | 2.34e-06 |
| 12093 | LRRC37A2 levels | GCST90469802 | 2.34e-06 |
| 12094 | PLAUR levels | GCST90012051 | 2.33e-06 |
| 12095 | Crohn's disease of large intestine | FING00000368 | 2.29e-06 |
| 12096 | Neutrophil percentage of white cells | GCST004633 | 2.29e-06 |
| 12097 | RSPO1/RSPO3 ratio | GCST90315790 | 2.27e-06 |
| 12098 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T297 | ECGA000297 | 2.25e-06 |
| 12099 | aparc-a2009s lh area G-postcentral | GCST90003324 | 2.22e-06 |
| 12100 | Falls/tendency to fall | FING00000530 | 2.20e-06 |
| 12101 | Felt very upset when reminded of stressful experience in past month | Traumatic events | UKBB00000243 | 2.20e-06 |
| 12102 | RGMB levels | GCST90242647 | 2.13e-06 |
| 12103 | Hypothyroidism | GCST90468138 | 2.12e-06 |
| 12104 | Degree of unsaturation | GCST90502746 | 2.12e-06 |
| 12105 | CDH3/NECTIN4 ratio | GCST90313952 | 2.11e-06 |
| 12106 | Free thyroxine levels within normal range in pregnancy | GCST90435196 | 2.09e-06 |
| 12107 | INHBB levels | GCST90469614 | 2.05e-06 |
| 12108 | Left-hemisphere limbic network to right-hemisphere default mode network white-matter structural connectivity | GCST90302735 | 2.03e-06 |
| 12109 | Thyroid peroxidase antibody positivity in pregnancy | GCST90435202 | 2.03e-06 |
| 12110 | Obesity due to excess calories | FING00000896 | 2.01e-06 |
| 12111 | GIMAP7 levels | GCST90469345 | 2.01e-06 |
| 12112 | Treatment/medication code - ramipril | Medications | UKBB00000856 | 2.00e-06 |
| 12113 | Lymphocyte percentage | Blood count | UKBB00000412 | 2.00e-06 |
| 12114 | FGFBP3 levels | GCST90469232 | 1.99e-06 |
| 12115 | Rash and other nonspecific skin eruption (PheCode 687.1) | GCST90476167 | 1.96e-06 |
| 12116 | Lymphocyte percentage (UKB data field 30180) | GCST90468083 | 1.94e-06 |
| 12117 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T296 | ECGA000296 | 1.91e-06 |
| 12118 | Raynauds phenomenon disease | GCST90271713 | 1.90e-06 |
| 12119 | Lymphocyte percentage of white cells | GCST90002389 | 1.80e-06 |
| 12120 | Ulcerative colitis, NAS | FING00001390 | 1.77e-06 |
| 12121 | F-sweet food liking (derived food-liking factor) | GCST90094854 | 1.75e-06 |
| 12122 | Invitation to complete online 24-hour recall dietary questionnaire, acceptance | Online follow-up - Diet by 24-hour recall | UKBB00000378 | 1.73e-06 |
| 12123 | Number of treatments/medications taken | Medications | UKBB00000542 | 1.71e-06 |
| 12124 | Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000811 | 1.70e-06 |
| 12125 | DTI TBSS L1 Genu of corpus callosum | GCST90384430 | 1.69e-06 |
| 12126 | Cough on most days | Medical information | UKBB00000153 | 1.69e-06 |
| 12127 | End-diastolic bi-ventricular shape (principal component 10) | GCST90448489 | 1.67e-06 |
| 12128 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T45 | ECGU000045 | 1.65e-06 |
| 12129 | Systolic blood pressure | GCST90301696 | 1.65e-06 |
| 12130 | GABBR2 levels | GCST90241230 | 1.64e-06 |
| 12131 | CCL5/SELP ratio | GCST90313705 | 1.60e-06 |
| 12132 | DTI autoptx FA ifo l tract | GCST90385124 | 1.58e-06 |
| 12133 | Interpolated Age of participant when non-cancer illness first diagnosed | Medical conditions | UKBB00000369 | 1.58e-06 |
| 12134 | Ximenoylcarnitine (C26:1) levels | GCST90200149 | 1.57e-06 |
| 12135 | T1 CAT volume R RightThalamus | GCST90384097 | 1.57e-06 |
| 12136 | Plasma lysine levels in chronic kidney disease | GCST90265459 | 1.54e-06 |
| 12137 | Carcinoma in situ of breast, intraductal (controls excluding all cancers) | FING00000240 | 1.53e-06 |
| 12138 | Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) levels | GCST90200105 | 1.52e-06 |
| 12139 | F2R/PDGFB ratio | GCST90314733 | 1.50e-06 |
| 12140 | ICD10 O60: Preterm labor and delivery | GCST90454242 | 1.49e-06 |
| 12141 | NFATC1/SPRY2 ratio | GCST90315539 | 1.48e-06 |
| 12142 | Ceramide (d18:1/24:0) levels | GCST90024046 | 1.47e-06 |
| 12143 | Appendectomy | FING00000104 | 1.46e-06 |
| 12144 | aseg lh intensity Putamen | GCST90003770 | 1.46e-06 |
| 12145 | rfMRI amplitudes (ICA100 node 7) | GCST90004595 | 1.45e-06 |
| 12146 | ZP3 levels | GCST90471105 | 1.45e-06 |
| 12147 | CEACAM16 levels | GCST90468689 | 1.43e-06 |
| 12148 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T44 | ECGU000044 | 1.41e-06 |
| 12149 | Cardiac conduction disorders (PheCode 426) | GCST90475952 | 1.39e-06 |
| 12150 | aseg rh volume Accumbens-area | GCST90002643 | 1.32e-06 |
| 12151 | Gestational diabetes mellitus | GCST90566419 | 1.30e-06 |
| 12152 | Family relationship satisfaction | Mental health | UKBB00000238 | 1.29e-06 |
| 12153 | PF4 levels | GCST90470211 | 1.28e-06 |
| 12154 | Mean arterial pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000444 | 1.28e-06 |
| 12155 | Mucosal proctocolitis | FING00000841 | 1.24e-06 |
| 12156 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54) | GCST90320873 | 1.20e-06 |
| 12157 | Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000812 | 1.19e-06 |
| 12158 | DBNL/PDGFB ratio | GCST90314422 | 1.09e-06 |
| 12159 | IDP dMRI TBSS FA Sagittal stratum R | GCST90003907 | 1.08e-06 |
| 12160 | Oxalate (ethanedioate) levels | GCST90199672 | 1.07e-06 |
| 12161 | PCOLCE levels | GCST90470175 | 1.06e-06 |
| 12162 | Mental and behavioural disorders due to use of tobacco | Mental and behavioural disorders due to psychoactive substance use | UKBB00000460 | 1.05e-06 |
| 12163 | LY6D/NECTIN4 ratio | GCST90315344 | 1.05e-06 |
| 12164 | IDP T1 FAST ROIs V cerebellum VIIb | GCST90002576 | 1.05e-06 |
| 12165 | CXCL10 levels | GCST90468923 | 1.02e-06 |
| 12166 | FGF2/HBEGF ratio | GCST90314811 | 1.02e-06 |
| 12167 | Recurrent or chronic depression | FING00001243 | 9.64e-07 |
| 12168 | Hayfever | GCST90468131 | 9.62e-07 |
| 12169 | aparc-a2009s rh volume G-postcentral | GCST90003026 | 9.44e-07 |
| 12170 | Estrone 3-sulfate metabolite level | GCST90616383 | 9.41e-07 |
| 12171 | Tobacco use disorder | mental disorders | UKBB00000824 | 9.19e-07 |
| 12172 | Repeated disturbing thoughts of stressful experience in past month | Traumatic events | UKBB00000750 | 9.17e-07 |
| 12173 | KRT18 levels | GCST90469716 | 9.14e-07 |
| 12174 | Chromatiales abundance in stool | GCST90032318 | 9.06e-07 |
| 12175 | IDP T1 SIENAX peripheral grey unnormalised volume | GCST90002427 | 8.95e-07 |
| 12176 | DLL1/NOTCH1 ratio | GCST90314498 | 8.80e-07 |
| 12177 | Hypertension | GCST90086091 | 8.76e-07 |
| 12178 | Acquired hypothyroidism (PheCode 244.2) | GCST90475650 | 8.61e-07 |
| 12179 | Light-intensity physical activity duration | GCST90061421 | 8.61e-07 |
| 12180 | Preterm labour and delivery | FING00001209 | 8.32e-07 |
| 12181 | DAB2/NCK2 ratio | GCST90314367 | 8.22e-07 |
| 12182 | CD27/ICAM3 ratio | GCST90313773 | 7.87e-07 |
| 12183 | Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levels | GCST90200145 | 7.64e-07 |
| 12184 | CDH2/SSC4D ratio | GCST90313951 | 7.37e-07 |
| 12185 | CD48/FCRL6 ratio | GCST90313840 | 7.35e-07 |
| 12186 | IDP dMRI TBSS ICVF Tapetum R | GCST90004373 | 7.35e-07 |
| 12187 | Colon cancer (PheCode 153.2) | GCST90475567 | 7.34e-07 |
| 12188 | PPBP levels | GCST90470289 | 7.29e-07 |
| 12189 | Diabetes (confirmatory factor analysis Factor 28) | GCST90309362 | 7.12e-07 |
| 12190 | IDP dMRI ProbtrackX OD ilf r | GCST90004465 | 7.08e-07 |
| 12191 | Colorectal cancer (PheCode 153) | GCST90475566 | 6.88e-07 |
| 12192 | All pneumoniae | FING00000065 | 6.88e-07 |
| 12193 | CHMP1A/RHOC ratio | GCST90314053 | 6.84e-07 |
| 12194 | IDP T1 FAST ROIs R cerebellum VIIIa | GCST90002580 | 6.66e-07 |
| 12195 | ITGB1BP2/SKAP2 ratio | GCST90315219 | 6.48e-07 |
| 12196 | CD48 levels | GCST90468635 | 6.38e-07 |
| 12197 | ICAM3/NOTCH1 ratio | GCST90315122 | 6.37e-07 |
| 12198 | NCR1 levels | GCST90470009 | 6.30e-07 |
| 12199 | TPSAB1 levels | GCST90470951 | 6.23e-07 |
| 12200 | Systolic blood pressure, manual reading | Blood pressure | UKBB00000810 | 6.22e-07 |
| 12201 | Secondary diabetes mellitus (PheCode 249) | GCST90475655 | 6.22e-07 |
| 12202 | FAS levels | GCST90427702 | 6.18e-07 |
| 12203 | REST UKBBICA NODEamps25 0006 | GCST90385489 | 6.10e-07 |
| 12204 | Melanoma | GCST90011809 | 6.09e-07 |
| 12205 | Treatment/medication code - omeprazole | Medications | UKBB00000852 | 5.76e-07 |
| 12206 | Frontotemporal dementia | FING00000560 | 5.68e-07 |
| 12207 | Nontoxic nodular goiter | endocrine/metabolic | UKBB00000529 | 5.43e-07 |
| 12208 | ATP5IF1/METAP1D ratio | GCST90313391 | 5.31e-07 |
| 12209 | CXCL11/DKK1 ratio | GCST90314334 | 5.28e-07 |
| 12210 | Non-cancer illness code, self-reported - migraine | Medical conditions | UKBB00000520 | 5.26e-07 |
| 12211 | Type 1 diabetes, definitions combined | FING00001380 | 5.24e-07 |
| 12212 | AGR3 levels | GCST90468254 | 5.16e-07 |
| 12213 | CSF2 levels | GCST90468884 | 5.06e-07 |
| 12214 | Left-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivity | GCST90302723 | 4.99e-07 |
| 12215 | DOK2/PPP1R12A ratio | GCST90314536 | 4.96e-07 |
| 12216 | Ceramide (d16:1/24:0) levels | GCST90025266 | 4.88e-07 |
| 12217 | Acute bronchitis | FING00000021 | 4.80e-07 |
| 12218 | BA-exvivo rh area BA2 | GCST90003222 | 4.79e-07 |
| 12219 | BA-exvivo lh area BA1 | GCST90003207 | 4.77e-07 |
| 12220 | RAB31 levels | GCST90087552 | 4.74e-07 |
| 12221 | Ulcerative colitis | GCST004133 | 4.73e-07 |
| 12222 | EDAR/IPCEF1 ratio | GCST90314578 | 4.52e-07 |
| 12223 | Milk type used - Skimmed | Diet | UKBB00000470 | 4.45e-07 |
| 12224 | AK1 levels | GCST90468269 | 4.20e-07 |
| 12225 | FOLR3/KLK8 ratio | GCST90314868 | 4.12e-07 |
| 12226 | Major dietary changes in the last 5 years - Yes, because of other reasons | Diet | UKBB00000423 | 4.02e-07 |
| 12227 | Thyroid peroxidase antibody levels in pregnancy | GCST90435201 | 3.96e-07 |
| 12228 | PDGFB/USP8 ratio | GCST90315633 | 3.92e-07 |
| 12229 | Regional enteritis (PheCode 555.1) | GCST90476066 | 3.55e-07 |
| 12230 | Barrett's esophagus | GCST003738 | 3.52e-07 |
| 12231 | CASP3/SERPINE1 ratio | GCST90313643 | 3.52e-07 |
| 12232 | LPO levels | GCST90469789 | 3.50e-07 |
| 12233 | aparc-DKTatlas rh area precuneus | GCST90003288 | 3.35e-07 |
| 12234 | Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044) | GCST90042535 | 3.34e-07 |
| 12235 | CSF3 levels | GCST90468886 | 3.30e-07 |
| 12236 | Plasma X-26054 levels in chronic kidney disease | GCST90266858 | 3.23e-07 |
| 12237 | MAVS/MED18 ratio | GCST90315389 | 3.20e-07 |
| 12238 | MAPRE3 levels | GCST90469859 | 3.19e-07 |
| 12239 | DSC2/SPINT1 ratio | GCST90314557 | 3.17e-07 |
| 12240 | IDP dMRI TBSS L2 Cingulum cingulate gyrus R | GCST90004157 | 3.06e-07 |
| 12241 | TNFRSF10B levels | GCST90012021 | 2.97e-07 |
| 12242 | GDF15 levels | GCST90469321 | 2.80e-07 |
| 12243 | IDP T1 SIENAX peripheral grey normalised volume | GCST90002426 | 2.77e-07 |
| 12244 | Taking other prescription medications | Medication | UKBB00000813 | 2.75e-07 |
| 12245 | DTI TBSS L3 Genu of corpus callosum | GCST90384526 | 2.55e-07 |
| 12246 | FCRL5/ICAM3 ratio | GCST90314802 | 2.48e-07 |
| 12247 | COPD/asthma/ILD related infections | FING00000353 | 2.29e-07 |
| 12248 | aparc-Desikan rh area precuneus | GCST90003131 | 2.21e-07 |
| 12249 | Hard cheese liking | GCST90094778 | 2.18e-07 |
| 12250 | NPTX1 levels | GCST90470078 | 2.10e-07 |
| 12251 | Degree of unsaturation | GCST90502734 | 2.10e-07 |
| 12252 | HEXIM1/NT5C3A ratio | GCST90315048 | 2.09e-07 |
| 12253 | Varicose veins of lower extremity (PheCode 454.1) | GCST90476013 | 2.01e-07 |
| 12254 | Acetone levels | GCST90092805 | 1.73e-07 |
| 12255 | Selective deficiency of immunoglobulin G [IgG] subclasses | FING00001288 | 1.71e-07 |
| 12256 | Psoriasis | GCST90468147 | 1.61e-07 |
| 12257 | Breakthrough COVID-19 susceptibility after at least one dose of a COVID-19 vaccine | GCST90448695 | 1.56e-07 |
| 12258 | FCRL6/GZMA ratio | GCST90314806 | 1.54e-07 |
| 12259 | EDIL3 levels | GCST90469072 | 1.40e-07 |
| 12260 | IDP dMRI ProbtrackX L1 ifo l | GCST90004258 | 1.31e-07 |
| 12261 | ENO2/PLXNA4 ratio | GCST90314665 | 1.27e-07 |
| 12262 | Milk type used: Full cream (UKB data field 1418_1) | GCST90132938 | 1.21e-07 |
| 12263 | KLRF1 levels | GCST90469712 | 1.18e-07 |
| 12264 | Physical activity (Total log acceleration 6pm-8pm) | GCST90061418 | 1.15e-07 |
| 12265 | A4GALT levels | GCST90427457 | 1.15e-07 |
| 12266 | Positional arithmetic | Fluid intelligence / reasoning | UKBB00000654 | 1.09e-07 |
| 12267 | Enthesopathy (PheCode 726.1) | GCST90476239 | 1.08e-07 |
| 12268 | SNAP23/TXLNA ratio | GCST90315857 | 1.07e-07 |
| 12269 | LGALS4/PCDH17 ratio | GCST90315315 | 1.00e-07 |
| 12270 | Physical activity | GCST90093324 | 9.94e-08 |
| 12271 | Influenza and pneumonia | FING00000679 | 9.65e-08 |
| 12272 | Total Dihexosylceramide levels | GCST90025193 | 9.14e-08 |
| 12273 | PBXIP1 levels | GCST90470164 | 7.72e-08 |
| 12274 | Fracture of lumbar spine and pelvis | FING00000556 | 7.60e-08 |
| 12275 | DTX3 levels | GCST90469048 | 7.38e-08 |
| 12276 | TGFBR2/TNFRSF1A ratio | GCST90315918 | 5.91e-08 |
| 12277 | IPCEF1/SPARC ratio | GCST90315186 | 5.54e-08 |
| 12278 | Left-hemisphere limbic network to amygdala white-matter structural connectivity | GCST90302741 | 5.47e-08 |
| 12279 | Other eye problems | Eyesight | UKBB00000610 | 4.42e-08 |
| 12280 | ADH4/KRT18 ratio | GCST90313192 | 4.20e-08 |
| 12281 | LACRT levels | GCST90469725 | 4.13e-08 |
| 12282 | COL6A3/SPON2 ratio | GCST90314179 | 3.87e-08 |
| 12283 | Coffee consumption (cups per day) | GCST90132984 | 3.45e-08 |
| 12284 | ADAMTS8/FAP ratio | GCST90313172 | 3.21e-08 |
| 12285 | F-dairy liking (derived food-liking factor) | GCST90094751 | 3.21e-08 |
| 12286 | Biological Father: High blood pressure | GCST90475243 | 2.91e-08 |
| 12287 | Intrinsic epigenetic age acceleration | GCST90014290 | 2.87e-08 |
| 12288 | PDGFA/SCARF1 ratio | GCST90315617 | 1.95e-08 |
| 12289 | CD160/CXCL16 ratio | GCST90313728 | 1.93e-08 |
| 12290 | F2R/SERPINE1 ratio | GCST90314735 | 1.78e-08 |
| 12291 | CD244/FCRL6 ratio | GCST90313765 | 1.45e-08 |
| 12292 | Hypercalcemia (PheCode 275.6) | GCST90475748 | 1.38e-08 |
| 12293 | RPN1 levels | GCST90240964 | 1.29e-08 |
| 12294 | IDP dMRI TBSS ISOVF Posterior corona radiata R | GCST90004503 | 9.08e-09 |
| 12295 | VEGFB levels | GCST90471035 | 8.86e-09 |
| 12296 | SSC4D/TNFSF10 ratio | GCST90315887 | 8.09e-09 |
| 12297 | Mineral and other dietary supplements - Calcium | Medication | UKBB00000471 | 7.45e-09 |
| 12298 | ICAM3/LY9 ratio | GCST90315121 | 6.33e-09 |
| 12299 | GNS levels | GCST90088460 | 6.09e-09 |
| 12300 | ALCAM/ENPP2 ratio | GCST90313236 | 4.80e-09 |
| 12301 | DSG3/NECTIN4 ratio | GCST90314560 | 4.43e-09 |
| 12302 | GZMA/TNFRSF4 ratio | GCST90315013 | 2.91e-09 |
| 12303 | Bacterial pneumoniae | FING00000139 | 2.66e-09 |
| 12304 | CD69/PLXNA4 ratio | GCST90313880 | 2.33e-09 |
| 12305 | NPDC1/TAFA5 ratio | GCST90315550 | 1.10e-09 |
| 12306 | BSG/LY9 ratio | GCST90313534 | 6.85e-10 |
| 12307 | PDGFA/USP8 ratio | GCST90315621 | 5.96e-10 |
| 12308 | IL10 levels | GCST90469546 | 5.90e-10 |
| 12309 | DKK1/PPCDC ratio | GCST90314477 | 4.21e-10 |
| 12310 | Tyrosine levels | GCST90500156 | 2.68e-10 |
| 12311 | Lager liking | GCST90094789 | 2.43e-10 |
| 12312 | CIAPIN1/VEGFC ratio | GCST90314071 | 8.55e-11 |
| 12313 | HBEGF levels | GCST90012067 | 7.50e-12 |